Indian Immunologicals Limited

Indian Immunologicals Limited
Company typeSubsidiary of National Dairy Development Board
IndustryBiotechnology
HeadquartersHyderabad,
India
Key people
Dr. K. Anand Kumar
(Managing Director)
Websitewww.indimmune.com

Indian Immunologicals Limited (IIL) is a subsidiary of the National Dairy Development Board. It is based in Hyderabad, Telangana, India.[1] IIL is registered in India as a Public Limited Company under the Companies Act, 1956 (Ministry of Corporate Affairs – MCA Services),[2] It was established in 1982 by the National Dairy Development Board.[3][4]

It is noted for developing veterinary and human vaccines for foot-and-mouth disease, rabies, bacterial vaccines, canine vaccines, hepatitis, measles, MMR and DPT.

IIL is a major supplier of DPT, TT and hepatitis B vaccines to India's large Universal Immunization Programme.[5][6] IIL has three vaccine manufacturing facilities in India. The Gachibowli-Hyderabad facility is engaged in the production of vaccines, while the Karakapatla-Hyderabad facility produces animal health formulations and human vaccines. IIL's facility in Ooty exclusively produces human anti-rabies vaccine, "Abhayrab". Pristine Biologicals Ltd is IIL's subsidiary in New Zealand and is involved in the production of serum used in the manufacture of vaccines.[7] Indian Immunologicals, IIL, on 25 November 2023 launched the measles and rubella vaccine 'Mabella' for children. A live-attenuated MR vaccine developed in partnership with Polyvac Institute of Vietnam was launched as part of the 25th celebrations of the IIL division Human Biologicals Institute (HBI) in Udhagamandalam (Ooty), Tamil Nadu.

  1. ^ "Two Central Government PSUs, namely, Indian Immunologicals Ltd (IIL) and BIBCOL have entered into a technology transfer agreement with Bharat Biotech". Press Information Bureau.
  2. ^ "Indian Immunologicals Limited Information – Indian Immunologicals Limited Company Profile, Indian Immunologicals Limited News on The Economic Times". The Economic Times. Archived from the original on 8 May 2019. Retrieved 24 March 2022.
  3. ^ "Indian Immunologicals eyes oral vaccine for cervical cancer". The Hindu BusinessLine. 28 June 2010. Retrieved 29 June 2010.
  4. ^ "Indian Immunologicals Limited". Internet Archive. Archived from the original on 15 April 2012.
  5. ^ "Indian Immunologicals to launch 4 vaccines in a year". The Economic Times. Retrieved 30 May 2010.
  6. ^ "Indian manufacturers account for 60% of vaccine supplies made to UNICEF". BioSpectrum. Retrieved 22 August 2017.
  7. ^ "IIL to invest rs 75 crore to expand Its karkapatla plant in telangana".